China Yongxin Pharmaceuticals Inc. Completes Reverse Merger; Company Begins Trading...

China Yongxin Pharmaceuticals Inc. Completes Reverse Merger; Company Begins Trading on OTC under Symbol ''CYXN''

CHANGCHUN, China & LOS ANGELES--(Business Wire)--
China Yongxin Pharmaceuticals Inc. (OTCBB:CYXN), a leading
manufacturer, distributor and retailer of pharmaceuticals in
Northeastern China, today announced that it has completed its
previously announced reverse merger with Nutradyne Group, Inc. and, to
better reflect the Company's true business, has changed its corporate
name to China Yongxin Pharmaceuticals Inc. as well as its ticker
symbol to "OTCBB: CYXN."

"We felt the corporate name change provided a much clearer
reflection of China Yongxin Pharmaceutical's true business operations
as one of the fastest growing manufacturing, distribution and retail
chain operators of pharmaceutical stores throughout China," said
Yongxin Liu, China Yongxin Pharmaceutical's Chairman and CEO. "More
importantly, with the last stage of the reverse merger completed and
access to the U.S. capital markets, we can now focus our efforts
towards the execution of our business plan which calls for the
creation of one of China's largest retail network of drug chain
stores."

To be added to China Yongxin Pharmaceuticals' investor lists,
please contact Haris Tajyar at htajyar@irintl.com or at 818-382-9702.

About China Yongxin Pharmaceuticals, Inc.

China Yongxin Pharmaceuticals Inc. (OTCBB:CYXN) was founded in
1993 as the Changchun Yongxin Dirui Medical Co. (Yongxin), a wholesale
drug distributor. Its products include Chinese traditional medicines,
Chinese traditional medical teas, chemical pharmaceutical
preparations, natural health products, healthy food, cosmetics, and
medical equipment. It began retail operations in 2001 and, in 2005,
gained franchise rights from the Medicine Shoppe(R) chain for China's
Jilin Province. By the end of 2007 it had 90 retail outlets as well as
wholesale distribution and manufacturing operations. Its primary
market has been in Northeastern China.

Forward Looking Statements: This news release contains certain
"forward-looking statements." Forward-looking statements are based on
current expectations and assumptions and are inherently subject to
risks and uncertainties, some of which cannot be predicted or
quantified, and many of which are beyond the Company's control. Actual
results could differ materially from these forward-looking statements
as a result of a number of risk factors detailed in the Company's
periodic reports filed with the SEC. Given these risks and
uncertainties, investors are cautioned not to place undue reliance on
such forward-looking statements and no assurances can be given that
such statements will be achieved. China Yongxin Pharmaceuticals Inc.
does not assume any duty to publicly update or revise the material
contained herein.

At Investor Relations Intl:
Haris Tajyar, Managing Partner
818-382-9702
htajyar@irintl.com

Copyright Business Wire 2008